Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection in the Elderly”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01222403
What this trial is testing

A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older

Who this might be right for
Influenza
Novartis Vaccines 767
Not applicableUnknownNCT04961502
What this trial is testing

Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions

Who this might be right for
Elderly People Institutionalized in Long-term Care Services
Gérond'if 80
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Early research (Phase 1)Study completedNCT00121771
What this trial is testing

Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 32
Large-scale testing (Phase 3)Study completedNCT04334577
What this trial is testing

Study on Efficacy of Attenuated Zoster Vaccine, Live

Who this might be right for
Herpes Zoster
Changchun BCHT Biotechnology Co. 25,000
Testing effectiveness (Phase 2)Looking for participantsNCT07582796
What this trial is testing

Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.

Who this might be right for
Respiratory Syncytial Virus Infections
Ab&B Bio-tech Co., Ltd.JS 470
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Testing effectiveness (Phase 2)Study completedNCT04712110
What this trial is testing

TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Takeda 200
Testing effectiveness (Phase 2)Study completedNCT00394160
What this trial is testing

Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)

Who this might be right for
Bronchiolitis
Organon and Co 12
Large-scale testing (Phase 3)Study completedNCT04435379
What this trial is testing

Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic

Who this might be right for
Infection, Respiratory Tract
Serum Life Science Europe GmbH 2,038
Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155
Not applicableStudy completedNCT00796393
What this trial is testing

Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.

Who this might be right for
Infectious Episodes (ENT, Gastro-intestinal and Pulmonary)
Institut Rosell Lallemand 200
Testing effectiveness (Phase 2)Looking for participantsNCT06873633
What this trial is testing

Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)
PENTA Foundation 120
Early research (Phase 1)Study completedNCT03382964
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers

Who this might be right for
Chikungunya
Valneva Austria GmbH 120
Not applicableStudy completedNCT04516187
What this trial is testing

Recognition of Serious Infections in the Elderly

Who this might be right for
Infection
KU Leuven 493
Not applicableUnknownNCT01424371
What this trial is testing

Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)

Who this might be right for
Influenza
Fraser Health 1,000
Large-scale testing (Phase 3)Study completedNCT00474487
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
Novartis Vaccines 2,831
Early research (Phase 1)Study completedNCT01019395
What this trial is testing

Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics

Who this might be right for
Gram Positive Bacterial Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 23
Early research (Phase 1)UnknownNCT04921111
What this trial is testing

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Who this might be right for
HPV Infection Vaccine Safety SCT1000
Sinocelltech Ltd. 240
Testing effectiveness (Phase 2)Looking for participantsNCT07036159
What this trial is testing

Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

Who this might be right for
Malaria
GlaxoSmithKline 238
Next Page